| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |